TY - JOUR
KW - Adult
KW - Alcohol-Related Disorders/complications
KW - Analgesics, Opioid/adverse effects/therapeutic use
KW - Female
KW - Humans
KW - Male
KW - Opioid-Related Disorders/diagnosis/etiology
KW - Oxycodone/adverse effects/therapeutic use
KW - Pain/drug therapy
KW - Prisoners/statistics & numerical data
KW - Risk Factors
KW - ROC Curve
KW - Street Drugs/adverse effects
KW - Substance Abuse Detection/methods
KW - Substance-Related Disorders/complications
KW - Surveys and Questionnaires
AU - J. S. Knisely
AU - M. J. Wunsch
AU - K. L. Cropsey
AU - E. D. Campbell
A1 - 
AB - The Prescription Opioid Misuse Index (POMI) was developed and used in a larger study designed to assess correlates of OxyContin abuse in pain patients prescribed OxyContin, patients treated for OxyContin addiction, and individuals incarcerated for OxyContin-related charges. The POMI was administered to 40 subjects with addiction problems and 34 pain patients who had received OxyContin for pain. Receiver operating characteristic curve analysis indicated that endorsing two or more of six items reliably classified a person as at risk for misuse of their medication. When comparing drug abuse/dependence in subjects classified as misusers or users, significantly more misusers received a diagnosis for alcohol (p < .01), illicit drugs (p < .05), and other prescription medications (p < .05) and reported greater lifetime use of alcohol (p < .002) and illicit drugs (p < .01). No between-group differences were found regarding psychiatric problems. The POMI appears to be a sensitive and specific instrument for identifying patients who misuse opioid medications.
BT - Journal of substance abuse treatment
C5 - Opioids & Substance Use; Measures
CP - 4
CY - United States
DO - 10.1016/j.jsat.2008.02.001
IS - 4
JF - Journal of substance abuse treatment
N2 - The Prescription Opioid Misuse Index (POMI) was developed and used in a larger study designed to assess correlates of OxyContin abuse in pain patients prescribed OxyContin, patients treated for OxyContin addiction, and individuals incarcerated for OxyContin-related charges. The POMI was administered to 40 subjects with addiction problems and 34 pain patients who had received OxyContin for pain. Receiver operating characteristic curve analysis indicated that endorsing two or more of six items reliably classified a person as at risk for misuse of their medication. When comparing drug abuse/dependence in subjects classified as misusers or users, significantly more misusers received a diagnosis for alcohol (p < .01), illicit drugs (p < .05), and other prescription medications (p < .05) and reported greater lifetime use of alcohol (p < .002) and illicit drugs (p < .01). No between-group differences were found regarding psychiatric problems. The POMI appears to be a sensitive and specific instrument for identifying patients who misuse opioid medications.
PP - United States
PY - 2008
SN - 1873-6483; 0740-5472
SP - 380
EP - 386
EP - 
T1 - Prescription Opioid Misuse Index: a brief questionnaire to assess misuse
T2 - Journal of substance abuse treatment
TI - Prescription Opioid Misuse Index: a brief questionnaire to assess misuse
U1 - Opioids & Substance Use; Measures
U2 - 18657935
U3 - 10.1016/j.jsat.2008.02.001
VL - 35
VO - 1873-6483; 0740-5472
Y1 - 2008
ER -